A real-world study conducted across 9 European countries found that bolus injection frequency and engagement with a smart pen to administer insulin were associated with improved glycemic control among ...

diabetes glucose monitor This study describes three cases in which patients experienced hyperglycemia despite dose titration due to incorrect injection. This article is written live from the American ...

The FINANCIAL — Eli Lilly and Company and Boehringer Ingelheim Pharmaceuticals, Inc. announced on December 15 that BASAGLAR (insulin glargine injection 100 units/mL) is available by prescription in ...

Tests in animals show the material works like the body's own system. Post content hidden for low score. Show… Post content hidden for low score. Show… Seems like a pretty interesting idea. I know a ...

Daily insulin jabs can be the bane of existence for people who live with type 2 diabetes, but an investigational once-weekly insulin shot may be a game changer for these folks. While the research is ...

Please provide your email address to receive an email when new articles are posted on . The FDA approved a novel, faster-acting insulin lispro injection to improve glycemic response in adults with ...

June 25 (Reuters) - (This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays. To receive the full newsletter in your inbox for free sign ...

GoodRx announced Thursday morning that it is working with Sanofi on a program to offer one of its leading insulin products to consumers for $35 per month. By visiting ...

University of Wisconsin alumnus Shawn Michels’ revolutionary injection invention is now on the market. Michels began developing the Steady Shot as an undergraduate at UW. Michels said Steady Shot is a ...

The report highlights that insulin-derived amyloidosis can mimic other injection-site reactions and should be considered when ...

Sept 28 (Reuters) - Eli Lilly and Co (LLY.N), opens new tab will lower the list price of its Insulin Lispro Injection in the United States by 40% from Jan. 1, the drugmaker said on Tuesday. The new ...

Needles aren’t popular. For people with type 1 diabetes (and some with type 2 diabetes) that can be a problem, since treatment requires regular injections with insulin. Now, researchers at MIT have ...